1. Home
  2. WING vs APGE Comparison

WING vs APGE Comparison

Compare WING & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wingstop Inc.

WING

Wingstop Inc.

HOLD

Current Price

$173.57

Market Cap

4.4B

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$132.87

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WING
APGE
Founded
1994
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.7B
IPO Year
2015
2023

Fundamental Metrics

Financial Performance
Metric
WING
APGE
Price
$173.57
$132.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
27
13
Target Price
$295.92
$109.67
AVG Volume (30 Days)
1.0M
5.1M
Earning Date
04-29-2026
05-12-2026
Dividend Yield
0.70%
N/A
EPS Growth
67.84
N/A
EPS
1.08
N/A
Revenue
$696,853,000.00
N/A
Revenue This Year
$17.20
N/A
Revenue Next Year
$15.86
N/A
P/E Ratio
$164.86
N/A
Revenue Growth
11.35
N/A
52 Week Low
$116.35
$34.34
52 Week High
$381.45
$133.85

Technical Indicators

Market Signals
Indicator
WING
APGE
Relative Strength Index (RSI) 62.95 81.38
Support Level $139.01 $73.70
Resistance Level $204.64 $133.16
Average True Range (ATR) 8.85 1.68
MACD 2.23 2.74
Stochastic Oscillator 89.53 98.03

Price Performance

Historical Comparison
WING
APGE

About WING Wingstop Inc.

Wingstop is a fast casual restaurant concept built around a simple chicken-centric menu. The firm primarily offers bone-in and boneless wings, tenders, and a chicken sandwich, customizable across 12 flavors. The banner generated $5.3 billion in system sales in 2025 across 3,056 units, with 85% located in the US. Wingstop largely operates as a franchisor, with 98% of units franchised, and earns revenue largely from collecting royalties and advertising fees paid by franchisees, with a smaller contribution from company-owned restaurant sales.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: